Literature DB >> 14607209

Determinants of failure to prescribe target doses of angiotensin-converting enzyme inhibitors for heart failure.

Juliet Manyemba1, Arduino A Mangoni, Keith W Pettingale, Stephen H D Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607209     DOI: 10.1016/s1388-9842(03)00055-2

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  The effects of heart failure on renal function.

Authors:  Suneel M Udani; Jay L Koyner
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

Review 3.  The implications of a growing evidence base for drug use in elderly patients Part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

4.  Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.

Authors:  Willeke N Kasje; Petra Denig; Roy E Stewart; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Journal:  Eur J Clin Pharmacol       Date:  2005-03-11       Impact factor: 2.953

5.  Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark.

Authors:  Lise Juul; Annelli Sandbaek; Anders Foldspang; Morten Frydenberg; Knut Borch-Johnsen; Torsten Lauritzen
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.